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ABSTRACT
Primary squamous cell carcinoma (SCC) of the colon and rectum is a rare malignancy. Overall there are less than 150 cases 
which have been reported and the first was case was reported in 1919.  We report a case of pure SCC involving the sigmoid colon. 
A 55 year old woman presented with chief complaints of bleeding per rectum for 5 months, anorexia and abdominal pain. Histological 
diagnosis of SCC was made by colonoscopy biopsy. Later it was confirmed by immunohistochemistry (IHC). Any other possible 
primary sites of malignancy were excluded. Complete surgical resection was performed. The prognosis of this disease seems to be 
worse than that of adenocarcinoma.
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Adenocarcinoma represents the vast majority of colorectal cancers (CRCs). Non-epithelial malignancies such as neuroendocrine tumors, sarcomas, and lymphoid tumors 
account for majority of the remaining cases. Squamous cell 
carcinoma (SCC) is of epithelial origin and the incidence of SCC 
of the colon and rectum has been reported to be 0.25–0.1/1000 
colorectal carcinomas [1]. Though neuroendocrine or squamous 
cell differentiation may be seen in colorectal adenocarcinoma, 
a pure colorectal SCC without anal canal involvement is an 
extremely rare tumor entity [2]. Because of the relative rarity of the 
disease, evidence based approach is not possible. Herein, we report 
a case of primary SCC of the sigmoid colon with local infiltration.
CASE REPORT
A 55 year old woman presented with complaints of painless 
bleeding per rectum for 5 months with anorexia and abdominal 
pain. She was referred to us after failed conservative treatments 
by a local physician. The patient had a history of abdominal 
hysterectomy for uterine fibroid 15 years back. There was no 
significant addiction or family history but was a known diabetic 
which was controlled with medications. 
She was hemodynamically stable and her systemic 
examination was normal. The patient had pallor and a 
mass palpable in the right lower abdomen, on examination. 
Colonoscopy revealed a large ulcero-proliferative growth in 
sigmoid colon compromising lumen [Fig. 1]. A biopsy was taken 
from the growth during colonoscopy, considering the diagnosis 
of malignancy like adenocarcinoma. However, histopathological 
examination proved this to be SCC [Fig. 2]. IHC (p63) [Fig. 3] of 
the specimen was also done for confirmation. Contrast enhanced 
abdominal computed tomography (CT) showed [Figure 4] an 
oval shaped heterogeneously enhancing soft tissue mass in right 
side of pelvis, measuring 4.5 cm x3.5 cm. The tumor had encased 
the right ureter partially and right sided hydronephro-ureteric 
changes were seen. Few pelvic nodes were also evident in scan. 
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Figure 1: Colonoscopy showing Ulcero-proliferative growth at 
sigmoid colon.
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CT scan of neck and chest did not reveal any abnormality. 
Both upper gastrointestinal endoscopy and laryngoscopy were 
within normal limit. Patient’s ECOG performance status was 01. 
On routine investigations, we found Hb%-7.3 gm%, urea-60 mg/
dl (normal 10-50 mg/dl), creatinine -1.6 mg/dl (normal 0.7-1.3 
mg/dl). Carcinoembryonic antigen (CEA) was 5.75ng/ml (normal 
≤4ng/ml). Clinical Stage III withT4N1M0 (as per AJCC 8th 
edition) was established. Preoperatively the anemia was corrected 
with blood transfusions.
The primary surgery was decided after multidisciplinary 
tumor board consultation. Intra-operatively, tumor was found 
in sigmoid colon adhered to posterior bladder wall encasing the 
lower part of right ureter. En-block resection of sigmoid colon 
with part of bladder and distal part of ureter was done. Mucosa of 
bladder was free. Primary closure of bladder with reimplantation 
of ureter over D-J stent was performed. Bowel continuity was 
maintained by stapled anastomosis between descending colon 
and rectum. Patient was discharged on 7th postoperative day in 
stable condition. Final pathological staging was pT4N0M0, 
Grade-2 SCC with all margins free. Patient received adjuvant 
chemotherapy of 8 cycles with – oxaliplatin (180 mg on 1st day) 
and capecitabine (1000 mg twice daily for next 14 days). Now 
patient is on follow up for last 18 months.
DISCUSSION
SCCs of the colon are an extremely rare clinical entity. The first 
case of a pure SCC of the colon was reported in the German 
literature by Schmidtmann in 1919 [3]. Colorectal SCC had 
been found mostly in rectum (93.4%) followed by right colon. 
Females are affected in 2/3rd cases with mean age of presentation 
between 55-65 years [4]. The mechanism underlying the origin 
of SCC from the colorectal mucosa remains unclear, but several 
mechanisms have been suggested. A proposed hypothesis is 
that SCC results from the proliferation of basal cells following 
mucosal injury and squamous differentiation within an adenoma 
[5]. Chronic inflammation (inflammatory bowel disease, human 
papillomavirus, amoebiasis, and schistosomiasis), radiation 
therapy and neoplasm in an adjacent organ (ovary, endometrium, 
cervix and prostate) have also been reported to be associated with 
some colonic SCCs [6].
Certain criteria must be satisfied before a diagnosis of primary 
SCC of the colon is made [7]. Metastasis from other sites to the 
bowel must be ruled out. A squamous - lined fistulous tract must 
not involve the affected bowel. SCCs of the anus with proximal 
extension must be excluded and its diagnosis must be confirmed 
by IHC analysis. Our case satisfied all these criteria. 
Clinical presentation, diagnosis, and staging of colon and 
colorectal SCC are similar to primary colonic adenocarcinoma 
[8].These tumors are usually aggressive and advanced at the time 
of presentation, leading to complications such as bleeding, bowel 
obstruction and urinary obstruction secondary to local spread 
[9]. In 1971 Comer et al. [10] suggested a poorer prognosis 
for patients with colorectal SCC than adenocarcinoma. Frizelle 
et al [6] had suggested nodal involvement, right sided lesions, 
ulcerated or annular carcinomas, grade 3 or 4 disease and stage 
IV disease to be associated with poor prognosis. Because of the 
rarity of these tumors, actual prognosis of patients with colorectal 
SCC is difficult to ascertain [10], but seems to be dismal.
The colorectal SCC seems to be more frequently locally 
invasive and more likely to involve regional lymphatics than 
adenocarcinoma, probably because of a delayed diagnosis. As a 
tumor marker, CEA may not be suitable as evident in our case. 
The proposed tumor marker for colorectal SCC is squamous 
cell carcinoma antigen (SCC Ag), which has already been used 
for SCC lung, uterus, cervix, esophagus, head and neck. Some 
literature highlighted its prognostic value as elevations of SCC Ag 
correlates with recurrence of this disease [11]. Unfortunately, we 
were not able to get SCC Ag levels for our patient. Staining with 
cytokeratin’s AE1/AE3, CK 5/6 and p63 for cells of squamous 
origin, assists in differentiating from adenocarcinoma [4].
Historically the treatment is primarily surgical, depending 
upon the location and stage of the disease. Adjuvant treatments 
can include Cisplatin/5-Fluorouracil based chemotherapy as used 
for head and neck SCC [6]. Juturi et al [12] have also reported 
encouraging results, and even complete remission in one case using 
the same combination chemotherapy with addition of Leucovorin. 
Copur et al [11] reported that cisplatin, etoposide, and 5fluorouracil 
combination chemotherapy was effective and serum SCC antigen 
level was a useful marker of response to chemotherapy. Recent 
series have shown survival advantages of primary chemo-
radiotherapy over conventional treatments [4]. However, the 
Figure 2: Histopathological examination showing keratin formation 
in SCC rectum specimen (in 100x hematoxylin and eosin stain).
Figure 3: Immunohistochemistry showing p63 stain positivity in 
SCC rectum specimen.
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condition has been encountered so rarely that adequate evaluation 
of adjuvant therapies has not been possible so far. 
CONCLUSION
Primary SCC of the colon and rectum is a rare tumor; however, it 
is important that surgeons and pathologists dealing with colorectal 
malignancy keep its existence in mind. Perhaps with a greater 
awareness we will see more cases reported resulting in a better 
understanding of this variant of colorectal carcinoma leading to 
its recognition as a regular entity.
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Figure 4: CT abdomen showing heterogeneously enhancing soft 
tissue mass in right side of pelvis.
